A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT)

Low Dosage Computerized Tomography (LDCT) has been shown to improve early detection of lung cancer and mortality rates in high-risk individuals, which was, however, limited by specifically coverage for heavy smokers and high rates of false positivity. Here, we aim to investigate a novel biomarker fo...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Wang, Xiaobing, Zhi, Xiuyi, Yang, Zhaogang, Tian, Haimei, Li, Yanfen, Li, Mo, Zhao, Wenya, Zhang, Chao, Wang, Teng, Liu, Jing, Shen, Di, Zheng, Cuining, Zhao, Dan, Yang, Sheng, Qi, Jun, Xin, Hongwu, Stojadinovic, Alexander, Avital, Itzhak, Lee, L. James, Rao, Jianyu, Zhang, Wei
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2017
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5542191/
https://ncbi.nlm.nih.gov/pubmed/28514755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17477
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料